Sökning: WFRF:(Yarmolinsky James)
> (2023) >
Genetically proxied...
Genetically proxied impaired GIPR signaling and risk of 6 cancers
-
- Rogers, Miranda (författare)
- University of Bristol
-
- Gill, Dipender (författare)
- Novo Nordisk A/S,Imperial College London
-
- Ahlqvist, Emma (författare)
- Lund University,Lunds universitet,Translationell muskelforskning,Forskargrupper vid Lunds universitet,Translational Muscle Research,Lund University Research Groups
-
visa fler...
-
- Robinson, Tim (författare)
- University of Bristol
-
- Mariosa, Daniela (författare)
- International Agency for Research on Cancer, World Health Organization
-
- Johansson, Mattias (författare)
- International Agency for Research on Cancer, World Health Organization
-
- Cortez Cardoso Penha, Ricardo (författare)
- International Agency for Research on Cancer, World Health Organization
-
- Dossus, Laure (författare)
- International Agency for Research on Cancer, World Health Organization
-
- Gunter, Marc J. (författare)
- International Agency for Research on Cancer, World Health Organization
-
- Moreno, Victor (författare)
- CIBER Epidemiology and Public Health (CIBERESP),Bellvitge University Hospital-IDIBELL,University of Barcelona
-
- Davey Smith, George (författare)
- University of Bristol
-
- Martin, Richard M. (författare)
- University Hospitals Bristol NHS Foundation Trust,University of Bristol
-
- Yarmolinsky, James (författare)
- University of Bristol
-
visa färre...
-
(creator_code:org_t)
- 2023
- 2023
- Engelska.
-
Ingår i: iScience. - 2589-0042. ; 26:6
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Preclinical and genetic studies suggest that impaired glucose-dependent insulinotropic polypeptide receptor (GIPR) signaling worsens glycemic control. The relationship between GIPR signaling and the risk of cancers influenced by impaired glucose homeostasis is unclear. We examined the association of a variant in GIPR, rs1800437 (E354Q), shown to impair long-term GIPR signaling and lower circulating glucose-dependent insulinotropic peptide concentrations, with risk of 6 cancers influenced by impaired glucose homeostasis (breast, colorectal, endometrial, lung, pancreatic, and renal) in up to 235,698 cases and 333,932 controls. Each copy of E354Q was associated with a higher risk of overall and luminal A-like breast cancer and this association was consistent in replication and colocalization analyses. E354Q was also associated with higher postprandial glucose concentrations but diminished insulin secretion and lower testosterone concentrations. Our human genetics analysis suggests an adverse effect of the GIPR E354Q variant on breast cancer risk, supporting further evaluation of GIPR signaling in breast cancer prevention.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- Cancer
- Genetics
- Health sciences
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
-
iScience
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Rogers, Miranda
-
Gill, Dipender
-
Ahlqvist, Emma
-
Robinson, Tim
-
Mariosa, Daniela
-
Johansson, Matti ...
-
visa fler...
-
Cortez Cardoso P ...
-
Dossus, Laure
-
Gunter, Marc J.
-
Moreno, Victor
-
Davey Smith, Geo ...
-
Martin, Richard ...
-
Yarmolinsky, Jam ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
iScience
- Av lärosätet
-
Lunds universitet